On 14 May 2026, the European Commission updated Annex XVII of the REACH Regulation to restrict four biocidal active substances—Irgarol 1051, Diuron, TCMS, and TPBP—in antifouling coatings for ships. From 1 June 2026, all ship coating products exported to the EU must be accompanied by an Active Substance Authorisation (ASA) certificate issued by ECHA. This development directly affects Chinese manufacturers of marine coatings, antifouling additives, and supporting testing service providers—raising compliance complexity and cost implications across export supply chains.

Event Overview

The European Commission published an amendment to REACH Annex XVII on 14 May 2026. The update introduces use restrictions on four biocidal substances—namely Irgarol 1051, Diuron, TCMS (trichloromethylsilane), and TPBP (triphenylborane phosphate)—in antifouling paints applied to ship hulls. Concurrently, the Commission mandated that, effective 1 June 2026, any ship coating product placed on the EU market must be supported by an ASA certificate issued by the European Chemicals Agency (ECHA). No further implementation details, transitional provisions, or grandfathering clauses have been publicly confirmed beyond this date and requirement.

Industries Affected by This Update

Direct Exporters of Marine Coatings

Companies exporting antifouling paints or ready-to-apply ship coatings to the EU will face immediate documentation obligations. The ASA requirement applies at product level—not merely at substance or formulation level—meaning each commercially distinct coating product must be linked to a valid ASA. Non-compliant shipments risk customs rejection or market withdrawal.

Suppliers of Antifouling Additives and Biocidal Intermediates

Manufacturers supplying Irgarol 1051, Diuron, TCMS, or TPBP—or formulations containing them—to coating formulators may see demand shifts. If downstream users reformulate to avoid restricted substances, additive suppliers may experience reduced orders for these four compounds. However, no restriction currently applies to non-antifouling applications of these substances under REACH.

Testing and Regulatory Compliance Service Providers

Laboratories and regulatory consultancies supporting EU market access will need to verify ASA validity and ensure alignment between product dossiers, ECHA’s Biocidal Products Regulation (BPR) database, and REACH Annex XVII compliance statements. The need for cross-referencing BPR authorisation status with REACH enforcement adds procedural layers not previously required for general REACH registration.

Coating Formulators and OEMs Integrating Antifouling Systems

Companies developing or integrating antifouling solutions—including those embedding biocidal additives into fouling-release polymers or hybrid systems—must confirm whether their final products fall within the scope of the Annex XVII restriction. The regulation targets ‘coatings applied to ship hulls’, but does not define ‘ship’ by tonnage, vessel type, or operational profile; interpretation remains subject to national enforcement authorities.

Key Actions for Affected Businesses

Monitor Official Updates on ECHA’s ASA Issuance Process

ECHA has not yet published standard operating procedures for ASA issuance specifically under this REACH Annex XVII amendment. Companies should track ECHA’s dedicated guidance page and national helpdesks for confirmation on application timelines, fee structures, and dossier requirements—particularly whether existing BPR approvals automatically satisfy the ASA condition.

Verify Product-Level Coverage and Substance Identity

Confirm whether each exported coating product contains any of the four listed substances above threshold levels. Note: The restriction applies regardless of concentration if the substance is intentionally added for biocidal function. Analytical verification and full ingredient disclosure—beyond SDS declarations—are likely necessary for ASA submission.

Distinguish Between Policy Signal and Enforceable Obligation

This amendment is legally binding as of 14 May 2026, but enforcement begins 1 June 2026. There is no published grace period. However, practical enforcement capacity—including customs inspection protocols and ASA validation mechanisms—remains unconfirmed. Businesses should treat the deadline as operative while observing early implementation patterns in key ports (e.g., Rotterdam, Hamburg).

Review Supply Chain Documentation Protocols Now

Prepare internal templates for ASA recordkeeping, supplier declarations, and batch-level traceability. Since ASA certificates are product-specific, companies may need to manage multiple ASA references per formulation variant (e.g., different viscosities, pigments, or packaging formats). Align procurement contracts with upstream suppliers to secure written commitments on ASA support and reformulation timelines.

Editorial Perspective / Industry Observation

Observably, this amendment signals a tightening convergence between REACH and the Biocidal Products Regulation (BPR) in regulating marine biocides—previously governed mainly under BPR. Analysis shows it does not introduce new hazard assessments for the four substances, but rather enforces existing BPR authorisation outcomes through REACH’s market surveillance framework. From an industry perspective, it functions less as a standalone regulatory shift and more as an enforcement lever: it makes BPR compliance mandatory for market access, even for products historically treated as ‘industrial mixtures’ under REACH. Current attention should focus on how national authorities interpret ‘coating applied to ship hulls’ and whether exemptions apply to vessels engaged solely in inland waterways or non-commercial use.

Current observation suggests this is both a signal and an enforceable requirement—but its operational impact hinges on ECHA’s capacity to issue ASAs at scale before June 2026, and on consistency across EU Member State market surveillance practices. Industry stakeholders should therefore treat it as a near-term compliance milestone, not a long-term strategic pivot.

This update underscores that regulatory convergence—rather than isolated rulemaking—is increasingly shaping chemical trade compliance. For exporters, it reinforces that substance-level authorisation status must now be verified not only under BPR, but also against REACH Annex XVII entry conditions. It is better understood as an enforcement extension of existing BPR obligations, rather than a de novo restriction regime.

Information Source: European Commission Official Journal announcement dated 14 May 2026; REACH Annex XVII amendment text (C/2026/3278); ECHA public Q&A on ASA issuance (as of 15 May 2026). Pending clarification: exact format and validation method for ASA certificates under this provision; applicability to coatings applied outside the EU but used on EU-registered vessels.